Last updated: April 2, 2025
Sponsor: Jagiellonian University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Injection Port
Treatment
Incision
Clinical Study ID
NCT06766656
1072.6120.115.2024
Ages 18-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Inclusion Criteria:
Age > 18 and < 80 years Informed consent Need for central venous access port implementation under local anesthesia
Exclusion
Exclusion Criteria:
Impaired blood clotting Ongoing antiplatelet drugs therapy, except acetylsalicylic acid Trauma or surgical past history on both shoulder girdles Known central venous thrombosis (subclavian vein, upper vena cava) Known pneumothorax Septic state Agranulocytosis
Study Design
Total Participants: 200
Treatment Group(s): 1
Primary Treatment: Incision
Phase:
Study Start date:
February 01, 2025
Estimated Completion Date:
January 31, 2026
Study Description
Connect with a study center
1Department of Intensive Interdisciplinary Care, Collegium Medicum, Jagiellonian University
Cracow,
PolandSite Not Available
Department of Intensive Interdisciplinary Care, Collegium Medicum, Jagiellonian University
Cracow,
PolandActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.